BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05925049-completion@plaintrial.com
DTSTAMP:20261027T204251Z
DTSTART;VALUE=DATE:20260331
SUMMARY:A Study Utilising Data From European Union (EU) National Multiple S
 clerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antib
 ody Among Participants Who Receive Subcutaneous Administration of Natalizu
 mab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS) — est
 imated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05925049
URL:https://plaintrial.com/trial/NCT05925049
END:VEVENT
END:VCALENDAR